levofloxacin has been researched along with ampicillin in 100 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (ampicillin) | Trials (ampicillin) | Recent Studies (post-2010) (ampicillin) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 14,685 | 1,251 | 2,266 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (7.00) | 18.2507 |
| 2000's | 48 (48.00) | 29.6817 |
| 2010's | 32 (32.00) | 24.3611 |
| 2020's | 13 (13.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Cui, S; McDermott, PF; Meng, J; Paulsen, I; White, DG; Zhao, S | 1 |
| Ki, CS; Kim, IS; Kim, S; Lee, K; Lee, NY; Oh, WS; Peck, KR; Song, JH | 1 |
| Barth, AL; Castanheira, M; Gales, AC; Nicoletti, AG; Pereira, AS; Pignatari, AC | 1 |
| Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
| Courvalin, P; Galimand, M; Périchon, B | 1 |
| Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, MA; Walsh, TR | 1 |
| Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Liu, T; Lv, J; Qian, Y; Wang, Y | 1 |
| Hovde, LB; Kroeger, LA; Mitropoulos, IF; Rotschafer, JC; Schafer, J | 1 |
| Billal, DS; Hotomi, M; Yamanaka, N | 1 |
| Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
| Baba, S; Billal, DS; Fujihara, K; Hotomi, M; Nishimura, T; Suzuki, K; Yamanaka, N | 1 |
| Liu, Y; Shi, W; Wang, M; Wu, S; Xu, X; Ye, X; Zhang, Y | 1 |
| Iredell, JR; Partridge, SR; Zong, Z | 1 |
| Baudry, PJ; DeCorby, M; Hoban, DJ; Mataseje, L; Mulvey, MR; Nichol, K; Zhanel, GG | 1 |
| Danese, P; DeVito, J; Franceschi, F; Lawrence, L; Sutcliffe, J | 1 |
| Fujimoto, K; Hirokawa, Y; Kashimoto, S; Kato, S; Kinoshita, H; Kitadai, N; Kojima, T; Nakata, K; Tanaka, T | 1 |
| Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Benton, BM; Draghi, DC; Krause, KM; Pillar, C; Sahm, DF; Thornsberry, C | 1 |
| Benton, BM; Debabov, DV; Difuntorum, S; Krause, KM; Renelli, M; Wu, TX | 1 |
| Craft, DW; Hachmeister, L; Hong, SG; Kim, SY; Moland, ES; Sayed, SD; Thomson, KS | 1 |
| Biek, D; Ge, Y; Sahm, DF; Talbot, GH | 1 |
| Aguilar, L; Biek, D; Fenoll, A; Giménez, MJ; Granizo, JJ; Robledo, O; Tarragó, D | 1 |
| Arakawa, Y; Kimura, K; Nagano, N; Nagano, Y; Tamai, K; Yanagisawa, H | 1 |
| Chen, Z; Deng, Y; Huang, L; Liu, J; Lü, D; Ma, J; Wang, M; Wang, X; Xu, X; Zeng, Z; Zhang, Y | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Artemenko, NK; Tetz, GV; Tetz, VV | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
| Bell, JM; Biedenbach, DJ; Jones, RN; Sader, HS; Turnidge, JD | 1 |
| Guo, Q; Hooper, DC; Wang, M; Wang, X; Wu, S; Xu, X; Ye, X | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Iwata, S; Murayama, SY; Nakayama, E; Sakata, H; Seki, C; Sunakawa, K; Sunaoshi, K; Ubukata, K | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Accogli, M; Caprioli, A; Carattoli, A; Cerquetti, M; Fortini, D; García-Fernández, A; Giufrè, M; Graziani, C; Luzzi, I | 1 |
| Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR; Paterson, DL | 1 |
| Han, S; Hwang, JK; Lee, K; Rukayadi, Y; Yong, D | 1 |
| Arhin, FF; Draghi, DC; Moeck, G; Parr, TR; Pillar, CM; Sahm, DF | 1 |
| Distèche-Nguyen, M; Gerards, T; Luxen, A; Miguet, L; Pasha, FA; Thomas, A; Zervosen, A | 1 |
| Ichiishi, S; Mikamo, H; Nakao, K; Shibata, T; Tanaka, K; Watanabe, K | 1 |
| Bae, S; Kang, Y; Kim, E; Lee, J; Lee, S; Yu, J | 1 |
| Ahmed, S; Calderwood, SB; Faruque, AS; Hooper, DC; Jacoby, GA; Khan, WA; Kim, HB; LaRocque, RC; Park, CH; Qadri, F; Salam, MA; Wang, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chang, SC; Chen, YC; Hsia, KC; Li, SY; Liao, MH; Lin, YC; Sheng, WH | 1 |
| Ardanuy, C; Brito-Avô, A; Gonçalo-Marques, J; Liñares, J; Morais, A; Pires, R; Rolo, D; Santos-Sanches, I | 1 |
| Barber, M; Eberly, LE; Feeney, LA; Miller, GH; Summers, A; Wortmann, G; Zapor, MJ | 1 |
| Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ | 1 |
| Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
| Badal, RE; Bouchillon, SK; DiPersio, J; Hawser, SP; Hoban, DJ; Labombardi, VJ | 1 |
| Bai, N; Cai, Y; Li, R; Liang, B; Liu, Y; Wang, R | 1 |
| Aytemir, MD; Ozçelik, B | 1 |
| Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Bortolozzo, Lde S; de Castro Siqueira, AM; Jorge, SD; Palace-Berl, F; Pasqualoto, KF; Tavares, LC; Zorzi, RR | 1 |
| Ferretti, MD; Kaufman, TS; Larghi, EL; Morel, AF; Neto, AT | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Dai, JG; Ge, GB; Hu, YC; Li, R; Lin, PC; Lin, S; Qiu, BL; Sun, ZH; Wang, LY; Wu, YZ; Xia, GY; Zhang, HW; Zhang, JF | 1 |
| Zhang, B | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Liu, H; Long, S; Rakesh, KP; Zha, GF | 1 |
| Dewangan, RP; Ghosh, JK; Gupta, A; Habib, S; Mitra, K; Pant, G; Verma, DP; Verma, NK | 1 |
| Cherubin, CE; Stratton, CW | 1 |
| Hayden, MK; Matushek, MG; Trenholme, GM | 1 |
| Barrett, JF; Foleno, BE; Frosco, MB; Smith, CE | 1 |
| Aikawa, N; Denno, R; Fujimoto, M; Hirata, AK; Ishibiki, K; Ishihara, R; Ishikawa, S; Iwai, S; Kinoshita, H; Koide, H; Kunimatsu, M; Manabe, T; Mashita, K; Mizuno, A; Morimoto, K; Mukaiya, M; Ohnishi, H; Ohtsuka, K; Sakaguchi, S; Shinagawa, N; Takuma, K; Tanimura, H; Umemoto, Y; Ushijima, Y; Yura, J | 1 |
| Lacy, MK; Lu, W; Nicolau, DP; Nightingale, CH; Quintiliani, R; Tessier, PR; Xu, X | 1 |
| Dabernat, H | 1 |
| Chiba, A; Harada, S; Hasegawa, M; Kaneko, A; Kobayashi, I; Koyama, H; Matsuzaki, K; Omika, K; Sasaki, J; Sato, Y | 1 |
| Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
| Furugo, I; Ishida, M; Takii, M; Ueda, M | 1 |
| Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yamanaka, N; Yoshimori, K | 1 |
| Hiyama, L; Miller, LG; Tang, A | 1 |
| Pistiolas, D; Robotis, J; Rokkas, T; Sechopoulos, P | 1 |
| Asoh, N; Mizota, T; Nagatake, T; Oishi, K; Qin, L; Watanabe, H; Watanabe, K | 1 |
| Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP; Um, S; Yan, SB | 1 |
| Fisher, A; Kahn, JB; Kaul, S; Khashab, M; Peterson, J | 1 |
| An, J; Hao, XY; Li, ZS; Wang, GC; Zuo, GY | 1 |
| Bian, ZQ; Han, J; Li, Y; Wang, GC; Zhang, YL; Zuo, GY | 1 |
| An, J; Bian, ZQ; Han, J; Hao, XY; Wang, GC; Zhang, YL; Zuo, GY | 1 |
| Abriouel, H; Benomar, N; Gálvez, A; Lavilla Lerma, L; Pérez Pulido, R; Sánchez Valenzuela, A | 1 |
| Kruhlak, NL; Zhu, X | 1 |
| Alonso, JM; Cantón, R; Cuartero, C; Del Campo, R; López, J; Lozano, S; Rodríguez, JD; Rodríguez-Domínguez, M; Ruiz-Garbajosa, P; Sánchez-Díaz, AM; Tedim, AP | 1 |
| Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Cataldi, V; Cellini, L; Ciccaglione, AF; Di Bartolomeo, S; Di Campli, E; Di Giulio, M; Grossi, L; Marzio, L; Nostro, A | 1 |
| Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S | 1 |
| Lenart, KS; Ostorhazi, E; Szabo, BG; Tirczka, T | 1 |
| Chen, M; Ding, Y; He, M; Jiang, F; Lei, T; Pang, R; Wang, J; Wei, L; Wu, Q; Wu, S; Zeng, H; Zhang, J | 1 |
| Dobashi, M; Ikeda, M; Ishii, J; Koguchi, D; Murakami, Y | 1 |
| Ho, CH; Huang, AH; Lai, CH; Lin, HF; Lin, TM; Su, PY | 1 |
| D'Angeli, F; Di Salvatore, V; Genovese, C; Nicolosi, D; Tempera, G | 1 |
| Bauer, M; Cheng, S; Gallardo, L; Hellman, J; Jackson, N; Konovalova, A; McNamara, C; Michel, LV; Pichichero, ME; Pierce, J; Snyder, E; Zavorin, M | 1 |
| Al Atbee, MYN; Jalil, MB | 1 |
| Hu, S; Lou, Z; Shen, Y; Tu, M | 1 |
| Chen, J; Ed-Dra, A; Wu, B; Yue, M; Zhang, Y; Zhou, H | 1 |
| Cheng, B; Guo, P; Jia, P; Xu, Y; Yang, Q; Zhang, H; Zhu, Y | 1 |
| Liu, CL; Liu, XT; Qiu, J; Wen, ZQ; Zhang, ZH; Zhu, SY | 1 |
| Cheng, WH; Ho, CH; Su, PY | 1 |
5 review(s) available for levofloxacin and ampicillin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents.
Topics: Anti-Bacterial Agents; Antiviral Agents; Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Triazines; Viruses | 2020 |
Bacteriological Studies of Venomous Snakebite Wounds in Hangzhou, Southeast China.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefazolin; Cefoxitin; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Snake Bites; Sulbactam; Venoms | 2022 |
2 trial(s) available for levofloxacin and ampicillin
| Article | Year |
|---|---|
Short report: antimicrobial susceptibility and genetic characteristics of Haemophilus influenzae isolated from patients with respiratory tract infections between 1987 and 2000, including beta-lactamase-negative ampicillin-resistant strains.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Ceftriaxone; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Japan; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Respiratory Tract Infections | 2007 |
Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pyelonephritis; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections | 2007 |
93 other study(ies) available for levofloxacin and ampicillin
| Article | Year |
|---|---|
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
Topics: Animals; Anti-Infective Agents; DNA Topoisomerases; Drug Resistance, Bacterial; Fluoroquinolones; Gene Targeting; Genes, Bacterial; Mutation; Salmonella Infections, Animal; Salmonella typhimurium | 2007 |
Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea.
Topics: Ampicillin Resistance; beta-Lactamases; Drug Resistance, Bacterial; Genes, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Korea; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Species Specificity | 2007 |
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Integrons; Latin America; Molecular Sequence Data; Plasmids | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
Topics: Acinetobacter; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Brazil; Codon, Terminator; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Pseudomonas putida; Transcription, Genetic | 2007 |
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents | 2007 |
Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cations; Drug Evaluation, Preclinical; Methicillin Resistance; Microbial Sensitivity Tests; Quinine; Staphylococcus aureus | 2007 |
Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ceftazidime; Colistin; Colony Count, Microbial; Drug Combinations; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests | 2007 |
Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae?
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Haemophilus influenzae; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2007 |
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes; Vancomycin Resistance; Viridans Streptococci | 2007 |
Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan.
Topics: Adolescent; Adult; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Child; Child, Preschool; Female; Gene Frequency; Genotype; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; Respiratory Tract Infections | 2007 |
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
RmtC 16S rRNA methyltransferase in Australia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Genes, rRNA; Humans; Methyltransferases; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis; RNA, Ribosomal, 16S | 2008 |
Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units.
Topics: Bacterial Proteins; beta-Lactamases; Canada; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gentamicins; Humans; Intensive Care Units; Microbial Sensitivity Tests | 2008 |
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
Topics: Anti-Infective Agents; Bacteria; Community-Acquired Infections; Cross Infection; Enterococcus; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Respiratory System; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 2008 |
Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Molecular Structure; Pleuromutilins; Polycyclic Compounds; Solubility; Stereoisomerism; Water | 2008 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Prospective Studies; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; United States | 2008 |
In vitro activity of telavancin against resistant gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 2008 |
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy.
Topics: Acinetobacter baumannii; Amikacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2008 |
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; United States | 2008 |
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Ceftaroline; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae | 2008 |
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Female; Genetic Heterogeneity; Humans; Infant, Newborn; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Phylogeny; Sequence Analysis, DNA; Streptococcus agalactiae | 2008 |
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
Topics: Acetyltransferases; Adolescent; Adult; Aged; Animals; Animals, Domestic; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cambodia; Cephalosporins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Female; Humans; Male; Mali; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Plasmids; Quinolones; Young Adult | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Effect of DNase and antibiotics on biofilm characteristics.
Topics: Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Deoxyribonucleases; Dose-Response Relationship, Drug; Drug Combinations; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Plankton | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
Topics: Anti-Bacterial Agents; Asia; Drug Resistance, Bacterial; Europe; Gram-Positive Bacteria; Humans; Latin America; Microbial Sensitivity Tests; North America; Pacific Ocean; Quality Control; Teicoplanin; Vancomycin | 2009 |
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2009 |
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Europe; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hospitalization; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Staphylococcus aureus; Streptococcus; United States | 2009 |
Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections.
Topics: Adolescent; Adult; Aged; Bacterial Capsules; Child; Child, Preschool; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant; Infant, Newborn; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Polymerase Chain Reaction; Streptococcus agalactiae | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
First report of plasmid-mediated quinolone resistance determinant qnrS1 in an Escherichia coli strain of animal origin in Italy.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Microbial Sensitivity Tests; Plasmids; Poultry; Poultry Diseases; Quinolones; Salmonella enterica | 2009 |
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Imipenem; India; Klebsiella; Quinolones; Thailand | 2009 |
In vitro activities of panduratin A against clinical Staphylococcus strains.
Topics: Anti-Bacterial Agents; Chalcones; Humans; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus; Zingiberaceae | 2009 |
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus | 2009 |
Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
Topics: Computational Biology; Computer Simulation; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ligands; Penicillin-Binding Proteins; Protein Binding; Streptococcus pneumoniae; Structure-Activity Relationship | 2009 |
Susceptibilities of 23 Desulfovibrio isolates from humans.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Desulfovibrio; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2009 |
Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance.
Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Ampicillin Resistance; beta-Lactamases; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Korea; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Penicillin-Binding Proteins; Population Surveillance; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Serotyping; Young Adult | 2010 |
Transferable quinolone resistance in Vibrio cholerae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chromosomes, Bacterial; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Quinolones; Vibrio cholerae | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; beta-Lactamases; Carbapenems; Cephalosporins; DNA Gyrase; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Taiwan | 2010 |
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Carrier Proteins; Child; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Molecular Epidemiology; Norfloxacin; Point Mutation; Portugal; Streptococcal Infections; Streptococcus pyogenes | 2010 |
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Dibekacin; Hospitals, Military; Humans; Microbial Sensitivity Tests; Warfare | 2010 |
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Topics: Abdomen; Amikacin; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests | 2010 |
In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation | 2010 |
A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities.
Topics: Animals; Anti-Infective Agents; Antiviral Agents; Bacteria; Cell Line; Chlorocebus aethiops; Drug Evaluation, Preclinical; Fungi; Herpesvirus 1, Human; Mannich Bases; Microbial Sensitivity Tests; Parainfluenza Virus 3, Human; Pyrones; Spectrum Analysis; Vero Cells | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Exploring 5-nitrofuran derivatives against nosocomial pathogens: synthesis, antimicrobial activity and chemometric analysis.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cross Infection; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Nitrofurans; Principal Component Analysis; Structure-Activity Relationship | 2014 |
Synthesis of symmetrically substituted 3,3-dibenzyl-4-hydroxy-3,4-dihydro-1H-quinolin-2-ones, as novel quinoline derivatives with antibacterial activity.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Quinolines; Quinolones; Structure-Activity Relationship | 2014 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Bysspectin A, an unusual octaketide dimer and the precursor derivatives from the endophytic fungus Byssochlamys spectabilis IMM0002 and their biological activities.
Topics: Anti-Bacterial Agents; Biocatalysis; Byssochlamys; Carboxylesterase; Carboxylic Ester Hydrolases; Dimerization; Dose-Response Relationship, Drug; Enzyme Inhibitors; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Polyketides; Staphylococcus aureus; Structure-Activity Relationship | 2018 |
Spermine-Conjugated Short Proline-Rich Lipopeptides as Broad-Spectrum Intracellular Targeting Antibacterial Agents.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Escherichia coli; Lipopeptides; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Proline; Spermine; Staphylococcus aureus | 2022 |
Assessment of the bactericidal activity of sparfloxacin, ofloxacin, levofloxacin, and other fluoroquinolones compared with selected agents of proven efficacy against Listeria monocytogenes.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Levofloxacin; Listeria monocytogenes; Listeriosis; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Comparison of the in vitro activity of levofloxacin and other antimicrobial agents against vancomycin-susceptible and vancomycin-resistant Enterococcus species.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Vancomycin | 1995 |
Assessment of the synergistic interactions of levofloxacin and ampicillin against Enterococcus faecium by the checkerboard agar dilution and time-kill methods.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents; beta-Lactam Resistance; Drug Therapy, Combination; Enterococcus faecium; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins | 1997 |
[Isolation rate of Enterococcus spp. from surgical infections and their susceptibilities].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Surgical Wound Infection; Thienamycins; Time Factors; Vancomycin | 1997 |
Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Levofloxacin; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Penicillins; Pneumococcal Infections | 1999 |
The bactericidal activity of levofloxacin against ampicillin-resistant and ampicillin-susceptible Haemophilus influenzae in comparison with ofloxacin, ciprofloxacin and sparfloxacin.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Haemophilus influenzae; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 1999 |
[In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Cefaclor; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Levofloxacin; Methicillin; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillins | 1999 |
Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefazolin; Cefotaxime; Cephalosporins; Clindamycin; Corynebacterium; Drug Resistance, Bacterial; Erythromycin; Eubacterium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Peptostreptococcus; Periodontitis; Staphylococcus; Streptococcus; Sulbactam; Thienamycins; Tooth Diseases | 2002 |
[Microbiological and clinical studies of Haemophilus influenzae isolated at Kitakyushu Municipal Medical Center from 1996 through 1999].
Topics: Adult; Aged; Ampicillin; Anti-Infective Agents; beta-Lactamases; Cefaclor; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Respiratory System; Seasons; Sulbactam; Thienamycins | 2002 |
[Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs].
Topics: Acute Disease; Ampicillin; Anti-Infective Agents; Azithromycin; Cefdinir; Cefpodoxime; Ceftizoxime; Cephalosporins; Clarithromycin; Enterobacteriaceae; Haemophilus influenzae; Humans; Levofloxacin; Ofloxacin; Penicillin G; Pharyngitis; Streptococcus pneumoniae; Streptococcus pyogenes; Tonsillitis | 2003 |
Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Biological Availability; Drug Therapy, Combination; Female; Humans; Levofloxacin; Ofloxacin; Polycystic Kidney, Autosomal Dominant; Pyelonephritis; Streptococcal Infections; Streptococcus agalactiae | 2006 |
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
Topics: Amoxicillin; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Omeprazole; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
Effect of recombinant human activated protein C on the bactericidal activity of human monocytes and modulation of pro-inflammatory cytokines in the presence of antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Blood Bactericidal Activity; Cytokines; Escherichia coli; Humans; In Vitro Techniques; Inflammation; Interleukin-1beta; Interleukin-8; Kinetics; Levofloxacin; Monocytes; Ofloxacin; Protein C; Recombinant Proteins; Tumor Necrosis Factor-alpha | 2007 |
Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Ceftazidime; Drug Synergism; Flavonols; Glycosides; Humans; Hypericum; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ofloxacin; Quercetin; Sputum | 2011 |
Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Berberine; Cefazolin; Drug Combinations; Drug Interactions; Drug Resistance, Multiple, Bacterial; Drug Synergism; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Ofloxacin | 2012 |
Isojacareubin from the Chinese herb Hypericum japonicum: potent antibacterial and synergistic effects on clinical methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Disk Diffusion Antimicrobial Tests; Drug Synergism; Drugs, Chinese Herbal; Genes, Bacterial; Hypericum; Inhibitory Concentration 50; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Plant Components, Aerial; Xanthenes | 2012 |
Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods.
Topics: Ampicillin; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Fermentation; Food Contamination; Food Microbiology; Genes, Bacterial; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Penicillins; Phenotype; Vancomycin | 2013 |
Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data.
Topics: Algorithms; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Bile Duct Diseases; Calibration; Chemical and Drug Induced Liver Injury; Cholestasis; Data Mining; Databases, Factual; Drug Labeling; Endpoint Determination; Humans; Levofloxacin; Liver; Naproxen; Product Surveillance, Postmarketing; Quantitative Structure-Activity Relationship; Toxicity Tests; Vitamins | 2014 |
The rise of ampicillin-resistant Enterococcus faecium high-risk clones as a frequent intestinal colonizer in oncohaematological neutropenic patients on levofloxacin prophylaxis: a risk for bacteraemia?
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; beta-Lactam Resistance; Blood; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Levofloxacin; Male; Middle Aged; Molecular Typing; Neutropenia; Prospective Studies; Real-Time Polymerase Chain Reaction; Risk Assessment | 2016 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Fluoroquinolones; Gastric Fundus; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pyloric Antrum; Rifabutin; Tetracycline; Young Adult | 2016 |
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
Clinical and microbiological characteristics of adult invasive Haemophilus influenzae infections: results of a 14-year single-center experience from Hungary.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Hungary; Incidence; Levofloxacin; Male; Middle Aged; Retrospective Studies; Sepsis | 2018 |
Prevalence, virulence, antimicrobial resistance, and molecular characterization of fluoroquinolone resistance of Vibrio parahaemolyticus from different types of food samples in China.
Topics: Amino Acid Substitution; Ampicillin; Animals; Anti-Bacterial Agents; China; DNA Gyrase; Drug Resistance, Bacterial; Fast Foods; Fluoroquinolones; Foodborne Diseases; Gentamicins; Humans; Levofloxacin; Plasmids; Prevalence; Seafood; Tetracycline; Vibrio parahaemolyticus; Virulence | 2020 |
Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Cefaclor; Cefazolin; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fosfomycin; Humans; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2020 |
Extensively drug-resistant Haemophilus influenzae - emergence, epidemiology, risk factors, and regimen.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Chloramphenicol; Cross Infection; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Incidence; Intensive Care Units; Levofloxacin; Logistic Models; Male; Microbial Sensitivity Tests; Taiwan; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |
Streptococcus agalactiae in pregnant women: serotype and antimicrobial susceptibility patterns over five years in Eastern Sicily (Italy).
Topics: Ampicillin; Anti-Bacterial Agents; Clindamycin; Erythromycin; Female; Humans; Levofloxacin; Microbial Sensitivity Tests; Penicillins; Pregnancy; Serogroup; Sicily; Streptococcus agalactiae; Vagina; Vancomycin | 2020 |
Ampicillin triggers the release of Pal in toxic vesicles from Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Escherichia coli; Escherichia coli Proteins; Gentamicins; Humans; Levofloxacin; Lipoproteins; Microbial Sensitivity Tests; Peptidoglycan; Sepsis | 2020 |
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections.
Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
Antimicrobial resistance and genomic investigation of non-typhoidal
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cefazolin; Doxycycline; Drug Resistance, Multiple, Bacterial; Genomics; Humans; Levofloxacin; Microbial Sensitivity Tests; Multilocus Sequence Typing; Outpatients; Salmonella; Salmonella Infections; Streptomycin; Tetracycline | 2022 |
In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.
Topics: Ampicillin; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Klebsiella pneumoniae; Levofloxacin; Meropenem; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Piperacillin; Tazobactam; Tigecycline | 2022 |
[Distribution and Drug Resistance of Pathogens in Oral Mucositis Associated with Chemotherapy in Patients with Malignant Hematopathy].
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Oral Ulcer; Penicillins; Stomatitis; Vancomycin | 2023 |
Molecular characterization of multidrug-resistant non-typeable Haemophilus influenzae with high-level resistance to cefuroxime, levofloxacin, and trimethoprim-sulfamethoxazole.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Cefuroxime; Ciprofloxacin; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |